Pages that link to "Q44612600"
Jump to navigation
Jump to search
The following pages link to Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption (Q44612600):
Displaying 50 items.
- P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception (Q24631289) (← links)
- Selective serotonin reuptake inhibitors as a novel class of immunosuppressants (Q26829415) (← links)
- Biomarkers predicting antidepressant treatment response: how can we advance the field? (Q27026147) (← links)
- Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein (Q28477346) (← links)
- Effects of sertraline and fluoxetine on p-glycoprotein at barrier sites: in vivo and in vitro approaches (Q28487360) (← links)
- Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans (Q28544844) (← links)
- Patterns of P-glycoprotein activity in the nervous system during vincristine-induced neuropathy in rats (Q28564505) (← links)
- P-glycoprotein inhibition increases the brain distribution and antidepressant-like activity of escitalopram in rodents (Q30544869) (← links)
- Blood-brain barrier active efflux transporters: ATP-binding cassette gene family (Q33985133) (← links)
- Drug resistance in brain diseases and the role of drug efflux transporters. (Q33988704) (← links)
- Systemic modulation of serotonergic synapses via reuptake blockade or 5HT1A receptor antagonism does not alter perithreshold taste sensitivity in rats (Q34048296) (← links)
- Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants (Q34099069) (← links)
- Pharmacogenetics of antidepressant response (Q34155796) (← links)
- Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity (Q34475376) (← links)
- Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief (Q34606838) (← links)
- The clinical pharmacokinetics of escitalopram (Q34610822) (← links)
- The Selective Serotonin Reuptake Inhibitor Paroxetine Does Not Alter Consummatory Concentration-Dependent Licking of Prototypical Taste Stimuli by Rats (Q35033624) (← links)
- Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings (Q35708089) (← links)
- Neuropsychiatric pharmacogenetics: moving toward a comprehensive understanding of predicting risks and response (Q35814369) (← links)
- Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. (Q36143108) (← links)
- Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats (Q36159042) (← links)
- The Influence of C3435T Polymorphism of the ABCB1 Gene on Genetic Susceptibility to Depression and Treatment Response in Polish Population - Preliminary Report. (Q36323164) (← links)
- Pharmacogenomics and antidepressant drugs (Q36438205) (← links)
- ABC drug transporter at the blood-brain barrier: effects on drug metabolism and drug response (Q36510891) (← links)
- The role of the transporter P-glycoprotein for disposition and effects of centrally acting drugs and for the pathogenesis of CNS diseases (Q36510902) (← links)
- Contribution of allelic variations in transporters to the phenotype of drug response (Q36511673) (← links)
- Antidepressant-drug interactions are potentially but rarely clinically significant (Q36538987) (← links)
- Active transport across the human placenta: impact on drug efficacy and toxicity (Q36545029) (← links)
- ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression (Q36591193) (← links)
- The selective serotonin reuptake inhibitor paroxetine decreases breakpoint of rats engaging in a progressive ratio licking task for sucrose and quinine solutions (Q36602077) (← links)
- Neuroendocrinological mechanisms of actions of antidepressant drugs (Q36728947) (← links)
- Epigenetic Modulation of Mood Disorders (Q36737217) (← links)
- Pharmacogenetics of chronic pain and its treatment. (Q36900075) (← links)
- Transporter-mediated uptake into cellular compartments (Q36985076) (← links)
- The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient. (Q37024001) (← links)
- Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein (Q37137438) (← links)
- Mechanisms of antidepressant resistance (Q37334088) (← links)
- Drug transporters: gatekeepers controlling access of xenobiotics to the cellular interior (Q37514340) (← links)
- Role of membrane transporters in the safety profile of drugs (Q37575644) (← links)
- Gender differences in antidepressant drug response (Q37806757) (← links)
- Paroxetine for the treatment of depression: a critical update (Q37977501) (← links)
- Pharmacogenetics of antidepressant drugs: current clinical practice and future directions (Q37989490) (← links)
- Psychotropic drug-drug interactions involving P-glycoprotein (Q38047816) (← links)
- PharmGKB summary: venlafaxine pathway (Q38152886) (← links)
- Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature (Q38414396) (← links)
- An in vitro evaluation of guanfacine as a substrate for P-glycoprotein. (Q38416672) (← links)
- The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study (Q38453405) (← links)
- Treatment-resistant depression: are animal models of depression fit for purpose? (Q38569708) (← links)
- Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain (Q38570611) (← links)
- Possibility of Predicting Serotonin Transporter Occupancy From the In Vitro Inhibition Constant for Serotonin Transporter, the Clinically Relevant Plasma Concentration of Unbound Drugs, and Their Profiles for Substrates of Transporters (Q38684291) (← links)